Drug development researchHumansGlioblastomaCell LineTumorDisintegrins
Lansbermin-I: A Snake Venom Disintegrin With Selective Cytotoxicity and Anti-Adhesive Effects Against Glioblastoma Cells.
Javier Orozco-Mera, Alejandro Montoya-Gómez, María José Sevilla-Sánchez, Ana María Arboleda Borrero, Mildrey Mosquera Escudero, Eliécer Jiménez-Charris
Published: 202610.1002/ddr.70218
Abstract
Glioblastoma is the most common and aggressive malignant brain tumor, characterized by poor response to current therapies and inevitable recurrence. Novel therapeutic strategies are urgently needed. Lansbermin-I, a disintegrin isolated from the venom…
Preview only. Read the full abstract at the source